PhRMA-backed alliance says it wants to 'modernize' the 340B program. Critics say the changes will only limit access

The Alliance to Save America’s 340B Program (ASAP 340B) is made up of a coalition of biopharma stakeholders who last week released a set of changes it thinks should be made to the discount program, sparking a rebuttal from opposing organizations who say the changes will only limit access to necessary meds.